Vaccination of metastatic melanoma patients with autologous dendritic cell (DC) derived-exosomes: results of thefirst phase I clinical trial

BACKGROUND: DC derived-exosomes are nanomeric vesicles harboring functional MHC/peptide complexes capable of promoting T cell immune responses and tumor rejection. Here we report the feasability and safety of the first Phase I clinical trial using autologous exosomes pulsed with MAGE 3 peptides for...

Descripción completa

Detalles Bibliográficos
Autores principales: Escudier, Bernard, Dorval, Thierry, Chaput, Nathalie, André, Fabrice, Caby, Marie-Pierre, Novault, Sophie, Flament, Caroline, Leboulaire, Christophe, Borg, Christophe, Amigorena, Sebastian, Boccaccio, Catherine, Bonnerot, Christian, Dhellin, Olivier, Movassagh, Mojgan, Piperno, Sophie, Robert, Caroline, Serra, Vincent, Valente, Nancy, Le Pecq, Jean-Bernard, Spatz, Alain, Lantz, Olivier, Tursz, Thomas, Angevin, Eric, Zitvogel, Laurence
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2005
Materias:
Protocol
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC554765/
https://www.ncbi.nlm.nih.gov/pubmed/15740633
http://dx.doi.org/10.1186/1479-5876-3-10

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC554765/
https://www.ncbi.nlm.nih.gov/pubmed/15740633
http://dx.doi.org/10.1186/1479-5876-3-10

Ejemplares similares